Oruka Therapeutics Inc (ORKA)

R&D Expense Growth

34.08%

Fiscal year · Period ending:

ORKA logo

ORKA R&D Expense Growth

Latest reported34.08%
ORKA FY R&D Growth (YoY) (0.00% → 34.08%)
High-resolution chart · PNG

ORKA r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Oruka Therapeutics Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
34.0794%
7,309.6742%
-77.3073%
-67.727%
177.0833%
172.3404%
-56.7587%
-69.8849%
13.9942%
74.8266%
25.5644%
92.1107%
168.1319%
0%
-100%
-68.971%
-9.2146%
-74.1501%
-52.2726%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.